Angelini G, Morozzi G, Delfino L, Pera C, Falco M, Marcolongo R, Giannelli S, Ratti G, Ricci S, Fanetti G
National Institute for Cancer Research, Genoa, Italy.
Hum Immunol. 1992 Jun;34(2):135-41. doi: 10.1016/0198-8859(92)90039-p.
We analyzed the distribution of DRB1, DQA1, DQB1, and DPB1 allelic variants in 48 rheumatoid arthritis (RA) patients, compared with 109 Italian random controls, using PCR amplification and hybridization with specific oligonucleotides. We confirm the previously reported increase of DR4 specificity, in comparison with healthy Italian individuals. In particular, we find a statistically significant positive association of DRB10401 and DRB10404 alleles with RA. However, when we compare the DR4+ groups, none of the DRB104 alleles is increased in the RA group. By sequence analysis, performed on 10 patients, we demonstrate that the DRB104 genes of RA show no difference from the DRB104 sequences previously published. From the molecular analysis of the other DRB1 polymorphic variants, we find a trend of positive association of DRB10101 in DR4-negative patients versus DR4-negative healthy controls and, in the group of DR4-negative and/or DR1-negative patients, a similar increase of DRB106. Also, we observe in RA patients a statistically significant increase of DQA10301 and DQB10302 accompanied by a significant decrease of DQA10201, DQA10501 and DQB10201. Finally, from the analysis of DPB1 gene, it can be assessed that the distribution of DPB1 alleles does not differ significantly between RA patients and healthy controls.
我们采用聚合酶链反应(PCR)扩增及与特异性寡核苷酸杂交的方法,分析了48例类风湿关节炎(RA)患者中DRB1、DQA1、DQB1和DPB1等位基因变体的分布情况,并与109名意大利随机对照者进行了比较。与健康的意大利个体相比,我们证实了之前报道的DR4特异性增加的情况。具体而言,我们发现DRB10401和DRB10404等位基因与RA存在统计学上显著的正相关。然而,当我们比较DR4阳性组时,RA组中DRB104等位基因均未增加。通过对10例患者进行序列分析,我们证明RA患者的DRB104基因与先前发表的DRB104序列没有差异。从对其他DRB1多态性变体的分子分析中,我们发现DR4阴性患者中DRB10101与DR4阴性健康对照相比有正相关趋势,并且在DR4阴性和/或DR1阴性患者组中,DRB106也有类似增加。此外,我们观察到RA患者中DQA10301和DQB10302有统计学上显著的增加,同时DQA10201、DQA10501和DQB10201有显著下降。最后,通过对DPB1基因的分析,可以评估出RA患者和健康对照之间DPB1等位基因的分布没有显著差异。